KAPA vs VRTX: Which Stock is Better?
Side-by-side comparison of Kairos Pharma Ltd and Vertex Pharmaceuticals Inc in 2026
KAPA
Kairos Pharma Ltd
$0.61
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | KAPA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $13.10M | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze KAPA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KAPA or VRTX a better investment?
Comparing KAPA and VRTX: Kairos Pharma Ltd has a market cap of $13.10M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KAPA and VRTX?
KAPA (Kairos Pharma Ltd) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KAPA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KAPA or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for KAPA.
Which company is more profitable: KAPA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for KAPA.
Which is the larger company: KAPA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $13.10M for KAPA.
Should I buy KAPA or VRTX in 2026?
Both KAPA and VRTX have investment merit. KAPA trades at $0.61 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KAPA and VRTX stock?
Key differences: Market Cap ($13.10M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).